SHARE:  
Updates in Pediatrics
Editor: Jack Wolfsdorf, MD, FAAP
header with photos of various children
September 15, 2021 | Volume 12 | Issue 38
Operative vs nonoperative management of acute pediatric Monteggia injuries
A Monteggia fracture is defined as a proximal 1/3 fracture (or plastic deformity without fracture) of the ulna with an associated radial head dislocation. There are 4 types (I-IV - Bado Classification. Type I = 70-75%) which describe the various positions of the ulna fracture and end-position of the radial head. While fairly uncommon (0.4% of forearm fractures in children) it usually results from a fall on an outstretched hand with hyperextension/hyperpronation of the forearm. Peak incidence; 4-10 years of age.

Symptoms include severe pain, swelling and tenderness and/or range of motion limitation which is not always obvious. Nerve damage occurs in 10-20% of children. Diagnosis is by plain radiography. Treatment (involving a complete fracture of the ulna) remains controversial.

A retrospective analysis of 73 children with Monteggia fractures/complete ulna fracture compared the outcomes (15.2 weeks) of 2 similarly matched groups treated by either immediate operative fixation or a trial of closed reduction and casting.

It appears that even in the presence of complete ulna fracture a trial of nonoperative management with closed reduction and casting may give comparable results to immediate surgery.
First oral blood thinner approved for children

Dabigatran (Pradaxa ®) is a direct, highly selective, reversible and potent thrombin inhibitor type anticoagulant that is now the first FDA approved oral blood thinner available for children 3 months – 11 years of age who have venous thromboembolisms and have received injectable blood thinners for at least 5 days. Peak plasma concentrations occur in 1-2 hours after ingestion and the half-life is 12-14 hours (in older volunteers). The most common adverse effects are digestive symptoms and bleeding

Buerger’s Disease (thromboangiitis obliterans) in an adolescent male
Buerger’s Disease is a rare, peripheral vascular disorder that mostly affects young/middle age cigarette smoking males which results in narrowing or blockage of veins/arteries of the extremities. While the exact cause is unknown, it has been suggested that genetic factors, the use of tobacco, autoimmune mechanisms and local trauma to the hands and feet contribute to its presentation. In most cases the first symptom is extreme pain of the lower arms and legs while at rest in sudden episodes lasting 1-4 weeks.

Affected individuals may have limb ulcers, numbness and tingling and lack of blood supply to the fingers and/or toes when exposed to cold temperatures (Raynaud’s phenomena). Diagnosis is made on history and characteristic features with confirmation by angiography. Treatment is symptomatic and supportive.

An interesting case-presentation of 16-year-old boy who smoked cigarettes and cannabis for 2 years prior to developing Buerger’s Disease reminds us that this fairly uncommon condition can occur in younger individuals.

Mayo Clinic COVID-19 Vaccine Tracker
REGISTER - LEARN - EARN CME
iLearn logo
Human Trafficking: Seeing the Unseen

This Virtual Grand Round was recorded LIVE and includes the post-session Q&A portion. This content is available for free - without CME credit (Fee may apply for those who wish to claim CME).
Nicklaus Children's Hospital Video Feature
Underwriting Opportunities
With a circulation of over 2000, Updates in Pediatrics offers an excellent opportunity to promote your brand at affordable rates. Contact Riccardo.Firmino@nicklaushealth.org


Advertising in this e-journal in no way implies endorsement of a product by Nicklaus Children's Hospital.